[On the treatment of hemoblastoses with N-diethyleneimidophosphonyl-N-phenylurea  (C 73)].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001388:Aziridines / Q000627:therapeutic use; D001389:Azirines / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D011087:Polycythemia Vera / Q000188:drug therapy*; D013852:Thiotepa / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D013852:Thiotepa
Zur Behandlung von Hämoblastosen mit N-Di-Athylenimido-Phosphonyl-N-Phenyl-Harnstoff (C 73)